Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 8;39(25):3315-3318.
doi: 10.1016/j.vaccine.2021.05.012. Epub 2021 May 12.

COVID-19 vaccine hesitancy among persons living in homeless shelters in France

C Longchamps  1 , S Ducarroz  2 , L Crouzet  2 , N Vignier  3 , L Pourtau  4 , C Allaire  5 , A C Colleville  5 , T El Aarbaoui  1 , M Melchior  6 ; ECHO study group
Affiliations

COVID-19 vaccine hesitancy among persons living in homeless shelters in France

C Longchamps et al. Vaccine. .

Abstract

COVID-19 vaccine hesitancy is frequent and can constitute a barrier to the dissemination of vaccines once they are available. Unequal access to vaccines may also contribute to socioeconomic inequalities with regard to COVID-19. We studied vaccine hesitancy among persons living in homeless shelters in France between May and June 2020 (n = 235). Overall, 40.9% of study participants reported vaccine hesitancy, which is comparable to general population trends in France. In multivariate regression models, factors associated with vaccine hesitancy are: being a woman (OR = 2.55; 95% CI 1.40-4.74), living with a partner (OR = 2.48, 95% CI 1.17-5.41), no legal residence in France (OR = 0.51, 95% CI 0.27-0.92), and health literacy (OR = 0.38, 95% CI 0.21, 0.68). Our results suggest that trends in vaccine hesitancy and associated factors are similar among homeless persons as in the general population. Dissemination of information on vaccine risks and benefits needs to be adapted to persons who experience severe disadvantage.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Ward J.K., Alleaume C., Peretti-Watel P. The French public's attitudes to a future COVID-19 vaccine: the politicization of a public health issue. Soc Sci Med. 2020;265 - PMC - PubMed
    1. Detoc M., Bruel S., Frappe P., Tardy B., Botelho-Nevers E., Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020;38(45):7002–7006. - PMC - PubMed
    1. Neumann-Böhme S., Varghese N.E., Sabat I., Barros P.P., Brouwer W., van Exel J., et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21(7):977–982. - PMC - PubMed
    1. Burger A.E., Reither E.N., Mamelund S.E., Lim S. Black-white disparities in 2009 H1N1 vaccination among adults in the United States: a cautionary tale for the COVID-19 pandemic. Vaccine. 2021;39(6):943–951. - PMC - PubMed
    1. Baggett T.P., Keyes H., Sporn N., Gaeta J.M. Prevalence of SARS-CoV-2 infection in residents of a large homeless shelter in Boston. J Am Med Assoc. 2020;323(21):2191–2192. - PMC - PubMed

Publication types